Novartis | NOVN - 贸易债权人





贸易债权人 更改 日
AbbVie USD 3.59B 28.65B 2025-12
Alcon AG USD 919M 7M 2026-03
Almirall EUR 258.05M 58.66M 2025-12
Amgen USD 19.52B 1.37B 2026-03
AstraZeneca USD 22.51B 2.78B 2026-03
Autolus Therapeutics Ltd USD 1.87M 1.21M 2026-03
Bayer EUR 6.59B 496M 2026-03
Biogen USD 358.5M 73.5M 2026-03
Bristol-Myers Squibb USD 4.23B 659M 2026-03
Eli Lilly USD 5.03B 350M 2026-03
Fresenius EUR 1.65B 564M 2025-12
Fresenius Medical Care EUR 890.43M 54.88M 2026-03
Genmab DKK 6M 2M 2025-09
Gilead Sciences USD 645M 70M 2026-03
GlaxoSmithKline GBP 14.34B 1.05B 2026-03
GRIFOLS EUR 841M 37.68M 2025-12
Hikma Pharmaceutical USD 715M 104M 2025-12
J&J USD 10.46B 1.53B 2026-03
Lakefront Biotherapeutics EUR 95.77M 8.88M 2026-03
Lonza CHF 471M 3M 2024-12
Merck EUR 2.13B 19M 2026-03
Merck USD 3.86B 541M 2026-03
Novartis USD 4.32B 134M 2026-03
Novartis USD 4.46B 99M 2025-12
Novo Nordisk DKK 14.8B 4.96B 2026-03
Orion EUR 150.3M 26.8M 2026-03
Pfizer USD 4.51B 734M 2026-03
Philips EUR 1.99B 63M 2026-03
Recordati EUR 306.9M 38.29M 2026-03
Regeneron Pharmaceuticals USD 1.03B 4.81B 2026-03
Roche Holding CHF 5.78B 1.27B 2025-12
Sanofi EUR 22.71B 219M 2026-03
UCB EUR 4.04B 755M 2025-12